AJ Vaccines A/S
AJ Vaccines is a global pharmaceutical company, established in 2017 after the acquisition of Statens Serum Institut (SSI) vaccine production. Today, we have a state-of-the-art production with 100 years of experience in producing high quality vaccines and biologics. We develop and manufacture vaccines against serious infectious diseases such as tetanus, diphtheria, tuberculosis (TB), pertussis (whooping cough) and polio. AJ Vaccines is proudly committed to support the Global Polio Eradication Initiative (GPEI), with our dose sparing technology providing a significant contribution to expanding inactivated polio vaccine supply. In addition, we manufacture Tuberculin Skin Test for screening and diagnosing of high-risk patients for infection with TB, as well as BCG Culture (Danish Strain 1331) for the standard treatment of intermediate and high-risk non-muscle invasive bladder cancer (NMIBC).
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2017
About Us
Our Mission
Create innovative vaccines, diagnostics and therapeutic solutions of high quality for the world.
Our People & Values
AJ Vaccines is headquartered in Copenhagen, Denmark and has 600+ employees globally.
Our core values are committed, proactive and respectful. We embrace and lean on these values to deliver on the aspirations in our Vision & Mission and to drive growth.